Contact
Please use this form to send email to PR contact of this press release:
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TO:
Please use this form to send email to PR contact of this press release:
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TO: